FDA recall D-0609-2025
Boothwyn Pharmacy LLC · Class II · drug
Product
Semaglutide, 2.5 mg/mL injection, 4 mL, Boothwyn Pharmacy
Reason for recall
Subpotent Drug
Distribution
U.S. Nationwide
Key facts
- Status
- Ongoing
- Initiation date
- 2025-07-09
- Report date
- 2025-09-10
- Voluntary/Mandated
- Voluntary: Firm initiated
- Location
- Kennett Square, PA, United States
Primary source
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0609-2025